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Morphological studies of pancreatic /I-cells have suggested the presence of discrete sensory and secretory domains. In the present study we now 
provide functional evidence by demonstrating polarity of insulin release by HIT-T15 cells. A significant diffusion barrier across a twin chamber 
culture system was verified in the presence of confluent HIT-T15 cells. When stimulated with sulphonylurea, ionophore or high potassium, insulin 
was preferentially released into the lower chamber irrespective of whether secretagogues were added to the upper or lower chambers. Vectorial 
insulin secretion may be a significant determinant of islet hormone paracrine interactions in the maintenance of glucose homeostasis. 
Epithelial polarity; HIT-T 15 )!I-cell/Insulin secretion 
1. INTRODUCTION reports documenting the functional polarization of in- 
sulin secretion. 
Many integral membrane proteins of epithelial cells, The introduction of polycarbonate filter inserts has 
such as receptors or transporters, show an asymmetric made it possible to culture epithelial cells in a more 
distribution on the surface of the cell. In turn, this physiologically appropriate environment, in which 
structural polarity ensures that specific epithelial func- medium has access to both apical and basolateral sur- 
tions, including transport, absorption and secretion, faces of the cell. These twin chamber systems have been 
are vectorial, in being restricted to different surfaces of widely used in studies of structural and functional 
the cell [1,2]. The establishment and maintenance of specialization to include demonstrations of (i) the 
epithelial cell polarity is a complex process involving the polarization of hormone secretion in Sertoli cells 
formation of cell-cell and cell-substratum contacts, and [ 12,131, (ii) receptor-directed polar lymphokine release 
the polarized distribution of membrane and by helper T cells [ 141 and (iii) a variety of vectorial func- 
cytoplasmic components. Moreover, it has been sug- tions in the Madin-Darby Canine Kidney (MDCK) cell 
gested that many pathological states may be associated line, such as transcytosis of growth factors [15], and the 
with a breakdown in polarity [3]. sorting of sphingolipids [16] or secretory proteins [17]. 
Diabetes mellitus is characterized by an inability to 
maintain glucose homeostasis as a result of partial or 
absolute insulin deficiency. Insulin is secreted from 
pancreatic P-cells, which comprise 60-80% of the en- 
docrine cells found in the islet of Langerhans. Islets also 
contain (Y- and PP cells, secreting glucagon and pan- 
creatic polypeptide respectively, and &cells, which 
secrete somatostatin. The anatomical relation between 
the individual cell types and the islet vasculature will 
clearly be critical in determining the physiological 
relevance of any islet paracrine effects. At present, 
although the interaction between the various islet cell 
types and their specific hormones remains unclear, 
there is compelling morphological evidence suggesting 
that insulin-secreting P-cells may be polarized into 
distinct sensory and secretory domains [4-111. 
However, to date, there have been no confirmatory 
In the present study, we have used this culture system 
to investigate potential bipolar insulin secretion by 
stimulating clonal HIT-T15 cells [18] with a range of 
secretagogues. Unlike dispersed adult islet P-cells, HIT- 
T15 cells can be conveniently grown to a high density in 
culture and we [19] and others [20,21] have shown that 
they retain the essential insulin secretory characteristics 
of isolated islets. Our results demonstrate the vectorial 
release of insulin by stimulated HIT-T15 cells. 
2. EXPERIMENTAL 
2.1 Materials 
Correspondence address: P. Hammonds, Diabetes Section, En- 
docrinology Division, Glaxo Incorporated, Five Moore Drive, 
Research Triangle Park, NC 27709, USA 
Tissue culture media, sera, antibiotics and plastics were purchased 
from Gibco Laboratories (New York, NY, USA). [‘2’I]Insulin and 
[3H]inulin were from Amersham Corporation (Arlington Hts, IL, 
USA). Transwell culture inserts were from Costar (Cambridge, MA, 
USA). Rat insulin standards were from Novo Laboratories (Danbury, 
CT, USA). All other reagents were purchased from Sigma Chemicals 
Company (St. Louis, Ml, USA). 
2.2. HIT-T15 culture 
HIT-T15 cells were generously supplied by Dr A.E. Boyd III 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
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(Baylor College of Medicine, Houston, TX, USA) and were routinely 
cultured in RPM1 1640, 10% fetal calf serum (v/v) and antibiotics as 
we have described [ 191. For polarization studies, cells were plated at 
a density of 4.5 x lo6 into 24.5 mm Transwell inserts containing 1.5 ml 
of culture medium, and grown until confluent (3-5 days) in 6-well 
multiwell plates. 2.6 ml of medium was added to the outside of each 
Transwell in order to achieve quivalent levels of medium between the 
inside of the insert and the multiwell. Because cell growth was rapid 
under these conditions, cultures were fed every 12 hours. 
2.3. Monolayer permeabiliiy 
The diffusion of [‘*‘I]insulin and [3H]inulin in the presence or 
absence of HIT-T15 cells was used to check for the presence of a 
significant diffusion barrier. isotopes were added separately to either 
the upper or lower chamber, and at timed intervals, 200 pl aliquots 
were removed from the opposite chamber and counted in the ap- 
propriate detector. This procedure was repeated, in triplicate, for 
each isotope, for each passage of HIT-T15 cells examined. 
2.4. Polarization studies 
On the day of the experiment, Transwell cultures were washed with 
normal culture medium, transferred to fresh multiwells, and then 
preincubated for 1 h in glucose-free medium. Cells were washed again 
and then incubated in culture medium supplemented with glucose (11 
mM) and additions as listed in section 3. Secretagogue challenges were 
added independently to the top or bottom compartment of the culture 
system. At timed intervals, equivalent aliquots of media were remov- 
ed from both compartments, centrifuged briefly to pellet any floating 
cells, and the supernatant stored at - 20°C prior to insulin assay. in- 
sulin release was measured by enzyme-linked immunosorbent assay 
(ELISA) [22]. 
2.5. Statistics 
Triplicate Transwell inserts were used for each test condition. All 
experiments were repeated using different passages of HIT-T15 cells. 
Data were analysed by analysis of variance (ANOVA) or the t-test for 
paired observations. 
3. RESULTS 
Monolayer permeability 
In order to verify that the experimental system was 
appropriate for defining polarity of &cell insulin 
release, the diffusion of labelled insulin across the 
Transwell membrane was measured in the presence or 
A Insulin B Inulin 
absence of confluent HIT-T15 cells. Fig. 1A shows that 
over a 20 min incubation period, confluent (3-5 days 
culture) HIT cells presented a significant (P<O.OOl) 
barrier to the diffusion of [‘*‘I]insulin across the mem- 
brane. In subsequent passages of HIT-T15 cells, a dif- 
fusion barrier was consistently observed between 5 and 
20 min (not shown). Further, for each passage of cells, 
similar results were obtained with 13H]inulin (Fig. IB). 
In all of the monolayer permeability experiments, 
similar results were obtained irrespective of whether 
isotopes were added to the upper or lower chamber. 
Basal insulin release 
Fig. 2 shows basal HIT-T15 insulin secretion in the 
Transwell system. Over a 20 min incubation period, in- 
sulin was released in a time-dependent manner into 
both chambers, and there was no significant difference 
in the levels secreted into each chamber. When the rate 
of diffusion of labelled insulin (Fig. 1A) is considered 
relative to the rate of basal insulin secretion (Fig. 2) it 
is clear that, in the presence of confluent HIT-T15 cells, 
the rate of diffusion of released insulin is slow com- 
pared to the rate at which insulin is secreted into the dif- 
ferent comp~tments‘ Further, unless the experiments 
exceeded 20 min or more, mixing of the contents of the 
upper and lower compartments was negligible, 
Stimulated insulin release 
Insulin secretion was potentiated by the addition of 
gliben~lamide (20 pgfml), A23187 (4 FM) or high 
potassium (40 mM). Fig. 3 shows that, in each case, in- 
sulin was preferentially released into the lower 
chamber, irrespective of whether the secretagogue was 
added to the upper or lower chamber. The ionophore 
A23 187 potentiated insulin secretion by up to 26-fold 
over basal, insulin levels being between 612-fold 
higher in the lower chamber compared to the upper 
chamber (Fig. 3A). The sulphonylurea glibenclamide 
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Fig. 1. Confluent HIT-15 cells present a significant ( ***, P<O.Ol (ANOVA)) diffusion barrier to [‘“‘I]insulin (A) or [3H]inulin (B). Label was 
added to the upper chamber at time ‘0’ and aliquots removed from the lower chamber at timed intervals. Results are expressed as percentage total 
counts recovered in the lower chamber. Data are given as mean f SE (n = 3). 
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Fig. 2. Basal insulin secretion in HIT-T15 cells is non-polar. Under 
basal conditions, there was no significant difference in the amounts of 
insulin secreted into the upper (open circles) or lower (closed circles) 
chambers. Data are given as mean rt SE (n = 7). 
(Fig. 3B) induced a similar response to A23187: basal 
insulin release was potentiated by up to 17-fold and in- 
sulin levels were between 7-l l-fold higher in the lower 
chamber. Finally, raising the potassium ion concentra- 
tion to 40 mM (Fig. 3C) evoked an exceptional 70-fold 
stimulation of insulin release over controls. Insulin 
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Fig. 3. Polarized secretion of insulin induced by secretagogues. 
Ionophore (A23187 : A), sulphonylurea (glibenclamide: B) or in- 
creased extracellular potassium ion concentrations (C) all‘significant- 
ly potentiated insulin secretion vectorially into the lower (closed 
circles) chamber, irrespective of whether secretagogue was added to 
the upper or lower chamber. Data are given as mean f SE (n = 3). (*, 
P<O.O5; **, P<O.Ol; ***, PcO.001; vs appropriate controls (t- 
test)). 
levels were between lo-17-fold-higher in the lower 
chamber in response to increased potassium. 
4. DISCUSSION 
In this study we have demonstrated vectorial secre- 
tion of insulin by clonal HIT-T15 P-cells. This is the 
first demonstration of functional polarization of the 
pancreatic P-cell, as predicted by previous ultlrastruc- 
tural studies. 
Early morphological studies suggested functional 
polarization in that insulin secretory granules appeared 
to be asymmetrically concentrated towards the 
‘capillary pole’ of the islet [5]. In addition, two studies 
by Orci and colleagues [9,10] support the hypothesis 
that the P-cell plasma membrane is polarized into 
specific domains. First, the asymmetrical emergence of 
budding RNA viruses was observed from different 
regions of infected islet monolayer cultures. Polarity of 
budding is a consequence of the asymmetrical insertion 
of viral envelope glycoproteins into distinct plasma 
membrane domains, and it was suggested that pan- 
creatic islet cells might also possess the ability to both 
sort out and target viral proteins to specific plasma 
membrane domains [9]. More recently, the liver-type 
glucose transporter (GLUT2) was shown to be present 
in the P-cell and localized to specific domains of the 
plasma membrane, characterized by the presence of 
microvilli which exclusively project into the in- 
tercellular space between adjacent endocrine cells [lo]. 
This implies that glucose uptake will be preferentially 
restricted to the basolateral regions of the P-cell mem- 
brane, rather in those regions closely associated with 
the capillary lumen. 
In situ morphological evidence of structural and 
functional polarization of P-cells has been provided by 
the elegant studies of Bonner-Weir who showed that /3- 
cells have two capillary faces [4-61. Partial degranula- 
tion of P-cells by prior in vivo treatment with 
sulphonylurea, revealed a pronounced polarity of in- 
sulin secretory granules towards the pole of the cell fac- 
ing the central capillary (arbitrarily designated the 
apical face). This suggests that insulin may also be 
secreted from specialized plasma membrane domains, 
the apparent polarity being masked by the intensive 
granulation present hroughout the normal islet [5]. In 
a further study using freeze fracture replicas, canaliculi 
were found to extend from one capillary face to the 
other along the interface of three or more P-cells [6]. 
Each canaliculus is a channel, closely associated with 
desmosomes, and across which the microvilli of adja- 
cent cells make contact. The discovery that microvilli 
are enriched in glucose transporters [IO] suggests that 
the canaliculi may represent sensory domains of the /3- 
cell. However, exocytotic figures were only seen on 
smooth lateral surfaces and on the pericapillary faces, 
and may alternatively depict secretory domains [6]. 
139 
Volume 272, number 1,2 FEBS LETTERS October 1990 
Many epithelial cells form more highly differentiated 
monolayers when grown on permeable supports in 
which the basolateral surface is directly accessible to the 
growth medium, and this is reflected in increased 
responsiveness to hormones [3]. This was also apparent 
in the present study with HIT-T15 cells in the Transwell 
system, since the levels of insulin released on stimula- 
tion with secretagogues were both more rapid and 
larger than previously recorded in standard plastic 
multiwell dishes. Further, the degree of stimulation of 
insulin relative to controls was also augmented. 
In order to demonstrate polarization, it was impor- 
tant to assess the monolayer permeability in the 
presence of HIT-T15 cells, and demonstrate a signifi- 
cant diffusion barrier to insulin during the course of the 
experiment. This was shown using both labelled hor- 
mone or inulin. Basal insulin release was similar in both 
chambers. However, when stimulated with 
secretagogues insulin secretion was vectorial and was 
preferentially released into the lower chamber, irrespec- 
tive of whether the secretagogue was added to the upper 
or lower chamber. The three secretagogues chosen all 
stimulate insulin release by causing an increase in in- 
tracellular calcium, but achieve this through distinct 
mechanisms. The ionophore A23 187 selectively facili- 
tates calcium entry. The sulphonylurea, glibenclamide, 
is thought to bind to the ATP-sensitive potassium chan- 
nel, thereby inducing depolarization of the P-cell mem- 
brane and calcium influx [23]. Raising the extracellular 
potassium concentration directly induces membrane 
depolarization and calcium influx. High potassium 
levels evoked the greatest increment of both insulin 
release and degree of polarization in HIT-T15 cells. 
The contribution of polarized P-cell function to the 
endocrine or paracrine function of the pancreas is at 
present unknown. It is possible that a failure in the pro- 
cesses involved in establishing P-cell polarity or alter- 
natively, a breakdown in polarity secondary to &cell 
stress, may contribute to impaired glucose homeostasis 
and the development of diabetes. Further studies using 
this system will help to define the role of establishing 
and maintaining polarity in normal and pathological p- 
cell function. 
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